H. Engler

1.1k total citations
24 papers, 868 citations indexed

About

H. Engler is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Molecular Biology. According to data from OpenAlex, H. Engler has authored 24 papers receiving a total of 868 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Physiology and 4 papers in Molecular Biology. Recurrent topics in H. Engler's work include Thyroid Disorders and Treatments (12 papers), Bone health and treatments (4 papers) and Nitric Oxide and Endothelin Effects (4 papers). H. Engler is often cited by papers focused on Thyroid Disorders and Treatments (12 papers), Bone health and treatments (4 papers) and Nitric Oxide and Endothelin Effects (4 papers). H. Engler collaborates with scholars based in Switzerland, United States and Australia. H. Engler's co-authors include Alvin Taurog, Walter F. Riesen, Martha L. Dorris, Beat Althaus, Jean-Jacques Staub, Toshiro Nakashima, D Burckhardt, Bruce D. Weintraub, Jürg Girard and Walter Riesen and has published in prestigious journals such as Endocrinology, The American Journal of Medicine and Clinical Chemistry.

In The Last Decade

H. Engler

24 papers receiving 805 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Engler Switzerland 13 524 139 116 90 77 24 868
L.E. Seargeant Canada 15 243 0.5× 403 2.9× 74 0.6× 55 0.6× 36 0.5× 30 812
Grażyna Bednarek-Tupikowska Poland 15 275 0.5× 118 0.8× 115 1.0× 107 1.2× 15 0.2× 72 771
George C. Schussler United States 19 743 1.4× 345 2.5× 146 1.3× 69 0.8× 20 0.3× 41 1.3k
Jeffrey D. Kearbey United States 12 475 0.9× 307 2.2× 91 0.8× 28 0.3× 34 0.4× 16 895
Tetsuya Kawahara Japan 15 88 0.2× 103 0.7× 106 0.9× 78 0.9× 65 0.8× 49 742
Rob Barto Netherlands 15 134 0.3× 156 1.1× 111 1.0× 52 0.6× 57 0.7× 35 643
Denis J. Glenn United States 14 86 0.2× 241 1.7× 102 0.9× 57 0.6× 68 0.9× 15 908
H Tamaki Japan 18 309 0.6× 168 1.2× 79 0.7× 46 0.5× 5 0.1× 45 800
W. J. Henderson United States 17 218 0.4× 256 1.8× 101 0.9× 104 1.2× 184 2.4× 36 932
Tomoko Ogawa Japan 18 154 0.3× 313 2.3× 126 1.1× 68 0.8× 12 0.2× 55 926

Countries citing papers authored by H. Engler

Since Specialization
Citations

This map shows the geographic impact of H. Engler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Engler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Engler more than expected).

Fields of papers citing papers by H. Engler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Engler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Engler. The network helps show where H. Engler may publish in the future.

Co-authorship network of co-authors of H. Engler

This figure shows the co-authorship network connecting the top 25 collaborators of H. Engler. A scholar is included among the top collaborators of H. Engler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Engler. H. Engler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Engler, H., et al.. (2012). Advancing haemostasis automation – successful implementation of robotic centrifugation and sample processing in a tertiary service hospital. Clinical Chemistry and Laboratory Medicine (CCLM). 51(6). 1273–1278. 10 indexed citations
2.
Joerger, Markus, Arnoud J. Templeton, Dieter Köberle, et al.. (2010). Procollagen type I N-propeptide is a predictor of skeletal morbidity in patients with malignant osteolytic bone disease on bisphosphonates. Cancer Chemotherapy and Pharmacology. 67(5). 1137–1144. 2 indexed citations
3.
4.
Stoffel, Karl, H. Engler, Markus S. Kuster, & Walter Riesen. (2006). Changes in Biochemical Markers after Lower Limb Fractures. Clinical Chemistry. 53(1). 131–134. 67 indexed citations
5.
Lehmann, Roger, et al.. (2001). Alterations of lipolytic enzymes and high‐density lipoprotein subfractions induced by physical activity in type 2 diabetes mellitus. European Journal of Clinical Investigation. 31(1). 37–44. 28 indexed citations
6.
Engler, H., et al.. (1999). Biochemical markers of bone turnover in patients with thyroid dysfunctions and in euthyroid controls: a cross-sectional study. Clinica Chimica Acta. 289(1-2). 159–172. 25 indexed citations
7.
Engler, H. & Walter F. Riesen. (1998). Effect of Thyroid Hormones on Lp(a) and Lipid Metabolism. Clinical Chemistry and Laboratory Medicine (CCLM). 36(9). 731–735. 10 indexed citations
8.
Engler, H., Dieter Koeberle, Beat Thuerlimann, Hans-Jörg Senn, & Walter F. Riesen. (1998). Diagnostic and Prognostic Value of Biochemical Markers in Malignant Bone Disease: A Prospective Study on the Effect of Bisphosphonate on Pain Intensity and Progression of Malignant Bone Disease. Clinical Chemistry and Laboratory Medicine (CCLM). 36(11). 879–885. 12 indexed citations
9.
Engler, H., et al.. (1996). Biochemical Markers of Bone Remodelling. Oncology Research and Treatment. 19(2). 126–131. 8 indexed citations
10.
11.
Engler, H. & Walter F. Riesen. (1993). Effect of thyroid function on concentrations of lipoprotein(a). Clinical Chemistry. 39(12). 2466–2469. 69 indexed citations
12.
Staub, Jean-Jacques, Beat Althaus, H. Engler, et al.. (1992). Spectrum of subclinical and overt hypothyroidism: Effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. The American Journal of Medicine. 92(6). 631–642. 260 indexed citations
13.
Engler, H., et al.. (1992). [Does isolated TSH elevation need treatment? Study of risk factors for the development of manifest hypothyroidism].. PubMed. 122(3). 66–9. 4 indexed citations
14.
Engler, H., et al.. (1992). [Diagnostic value of autoantibodies against microsomal thyroid peroxidase (anti-TPO)].. PubMed. 122(51-52). 1976–80. 7 indexed citations
15.
16.
Taurog, Alvin, et al.. (1983). Mechanism of Action of Thioureylene Antithyroid Drugs in the Rat: Possible Inactivation of Thyroid Peroxidase by Propylthiouracil*. Endocrinology. 113(1). 362–370. 46 indexed citations
17.
Engler, H., et al.. (1983). Reversible and Irreversible Inhibition of Thyroid Peroxidase-Catalyzed Iodination by Thioureylene Drugs*. Endocrinology. 112(1). 86–95. 73 indexed citations
18.
19.
Engler, H., Alvin Taurog, & Toshiro Nakashima. (1982). Mechanism of inactivation of thyroid peroxidase by thioureylene drugs. Biochemical Pharmacology. 31(23). 3801–3806. 89 indexed citations
20.
Studer, H, et al.. (1978). Transformation of Normal Follicles into Thyrotropin-Refractory “Cold” Follicles in the Aging Mouse Thyroid Gland*. Endocrinology. 102(5). 1576–1586. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L.E. Seargeant Breakdown of academic impact, for papers by Grażyna Bednarek-Tupikowska Breakdown of academic impact, for papers by George C. Schussler Breakdown of academic impact, for papers by Jeffrey D. Kearbey Breakdown of academic impact, for papers by Tetsuya Kawahara Breakdown of academic impact, for papers by Rob Barto Breakdown of academic impact, for papers by Denis J. Glenn Breakdown of academic impact, for papers by H Tamaki Breakdown of academic impact, for papers by W. J. Henderson Breakdown of academic impact, for papers by Tomoko Ogawa
Rankless by CCL
2026